MOH on NYSE

Molina Healthcare

Logo: Molina Healthcare, Public domain, via Wikimedia Commons⁶

American-managed healthcare insurance company

Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.³ Its shares trade on NYSE under the symbol MOH.¹ Wikipedia text CC BY-SA 4.0

$206.86 down 5.64 (2.65%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 21, 2026.

Overview

1980Founded¹

Compare with Humana, Centene Corporation or Elevance Health, Inc., or pick any stock.

TickerMOH on NYSE¹
Industryhealth care industry¹
HeadquartersLong Beach¹
Websitemolinahealthcare.com
Legal formDelaware corporation¹
Incorporated inDE⁷
Business address200 Oceangate, Suite 100, Long Beach, Ca 90802⁷
Filer categoryLarge accelerated filer⁷
LEI549300NQQCEQ46YHZ591⁴
StatusActive⁴
LEI statusIssued and current⁴
Registered addressc/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States⁴
Registered withDivision of Corporations, Department of State, 3551135⁴

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

1.7%Operating margin¹⁰

1.0%Net margin¹⁰

11.7%Revenue growth, 2025¹⁰

11.6%Return on equity¹⁰

0.93×Debt to equity¹⁰

-$636.0MFree cash flow¹⁰

Where the money goes

Where each dollar of revenue went, fiscal 2025

Cost of revenueOther costs

Cost of revenue87¢$39.5B
Other costs12¢$5.3B
Income tax0¢$117.0M
Profit1¢$472.0M

Out of $45.4B in revenue.¹⁰

Financial statements

Revenue¹¹¹²¹³¹⁴¹⁰$45.4B in 2025+170% since 2019

Gross profit¹⁵$2.5B in 2020+8% since 2019

Operating income¹¹¹²¹³¹⁴¹⁰$781.0M in 2025−25% since 2019

Net income¹¹¹²¹³¹⁴¹⁰$472.0M in 2025−36% since 2019

Every line of the income statement as filed: the last 3 fiscal years, latest first.¹⁰

Period ending	2025-12-31	2024-12-31	2023-12-31
Premium revenue	$43.1B	$38.6B	$32.5B
Premium tax revenue	$1.9B	$1.5B	$1.1B
Investment income	$420.0M	$452.0M	$394.0M
Other revenue	$91.0M	$85.0M	$80.0M
Total revenue	$45.4B	$40.6B	$34.1B
Medical care costs	$39.5B	$34.4B	$28.7B
General and administrative expenses	$3.0B	$2.7B	$2.5B
Premium tax expenses	$1.9B	$1.5B	$1.1B
Depreciation and amortization	$195.0M	$186.0M	$171.0M
Other	$90.0M	$100.0M	$128.0M
Total operating expenses	$44.6B	$38.9B	$32.5B
Operating income	$781.0M	$1.7B	$1.6B
Interest expense	$192.0M	$118.0M	$109.0M
Income before income tax expense	$589.0M	$1.6B	$1.5B
Income tax expense	$117.0M	$410.0M	$373.0M
Net income	$472.0M	$1.2B	$1.1B
Basic (in dollars per share)	$8.93	$20.52	$18.91
Diluted (in dollars per share)	$8.92	$20.42	$18.77
Basic (in shares)	52.8M shares	57.4M shares	57.7M shares
Diluted (in shares)	52.9M shares	57.7M shares	58.1M shares

Total assets¹⁵¹¹¹²¹³¹⁴¹⁰$15.6B in 2025+129% since 2019

Total liabilities¹⁵¹¹¹²¹³¹⁴¹⁰$11.5B in 2025+138% since 2019

Shareholders’ equity¹²¹³¹⁴¹⁰$4.1B in 2025+108% since 2019

Cash¹¹¹²¹³¹⁴¹⁰$4.2B in 2025+73% since 2019

Long-term debt¹⁵¹¹¹²¹³¹⁴¹⁰$3.8B in 2025+204% since 2019

Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.¹⁰

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$4.2B	$4.7B	$4.8B
Investments	$4.0B	$4.3B
Receivables	$3.5B	$3.3B
Prepaid expenses and other current assets	$655.0M	$487.0M
Total current assets	$12.4B	$12.8B
Property, equipment, and capitalized software, net	$301.0M	$288.0M
Goodwill and intangible assets, net	$2.2B	$1.9B
Restricted investments	$299.0M	$286.0M
Deferred income taxes, net	$178.0M	$207.0M
Other assets	$147.0M	$138.0M
Total assets	$15.6B	$15.6B
Medical claims and benefits payable	$4.9B	$4.6B	$4.2B	$3.5B
Amounts due government agencies	$1.3B	$1.9B
Accounts payable, accrued liabilities and other	$1.1B	$1.3B
Deferred revenue	$66.0M	$51.0M
Total current liabilities	$7.4B	$7.9B
Long-term debt	$3.8B	$2.9B
Finance lease liabilities	$184.0M	$195.0M
Other long-term liabilities	$173.0M	$120.0M
Total liabilities	$11.5B	$11.1B
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024	$0	$0
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	$0	$0
Additional paid-in capital	$452.0M	$462.0M
Accumulated other comprehensive income (loss)	$15.0M	-$57.0M
Retained earnings	$3.6B	$4.1B
Total stockholders equity	$4.1B	$4.5B	$4.2B	$3.0B
Total liabilities and stockholders equity	$15.6B	$15.6B
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	150.0M shares	150.0M shares
Common stock, shares, outstanding (in shares)	51.0M shares	56.0M shares
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	20.0M shares	20.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$4.2B	$4.7B	$4.8B
Investments	$4.0B	$4.3B
Receivables	$3.5B	$3.3B
Prepaid expenses and other current assets	$655.0M	$487.0M
Total current assets	$12.4B	$12.8B
Property, equipment, and capitalized software, net	$301.0M	$288.0M
Goodwill and intangible assets, net	$2.2B	$1.9B
Restricted investments	$299.0M	$286.0M
Deferred income taxes, net	$178.0M	$207.0M
Other assets	$147.0M	$138.0M
Total assets	$15.6B	$15.6B
Medical claims and benefits payable	$4.9B	$4.6B	$4.2B	$3.5B
Amounts due government agencies	$1.3B	$1.9B
Accounts payable, accrued liabilities and other	$1.1B	$1.3B
Deferred revenue	$66.0M	$51.0M
Total current liabilities	$7.4B	$7.9B
Long-term debt	$3.8B	$2.9B
Finance lease liabilities	$184.0M	$195.0M
Other long-term liabilities	$173.0M	$120.0M
Total liabilities	$11.5B	$11.1B
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024	$0	$0
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	$0	$0
Additional paid-in capital	$452.0M	$462.0M
Accumulated other comprehensive income (loss)	$15.0M	-$57.0M
Retained earnings	$3.6B	$4.1B
Total stockholders equity	$4.1B	$4.5B	$4.2B	$3.0B
Total liabilities and stockholders equity	$15.6B	$15.6B
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	150.0M shares	150.0M shares
Common stock, shares, outstanding (in shares)	51.0M shares	56.0M shares
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	20.0M shares	20.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares

Cash from operations¹¹¹²¹³¹⁴¹⁰-$535.0M in 2025

Capital spending¹¹¹²¹³¹⁴¹⁰$101.0M in 2025+77% since 2019

Free cash flow¹¹¹²¹³¹⁴¹⁰-$636.0M in 2025

Share buybacks¹¹¹²¹³¹⁴¹⁰$1.0B in 2025+2028% since 2019

Every line of the cash flow as filed: the last 3 fiscal years, latest first.¹⁰

Period ending	2025-12-31	2024-12-31	2023-12-31
Net income	$472.0M	$1.2B	$1.1B
Depreciation and amortization	$195.0M	$186.0M	$171.0M
Deferred income taxes	$43.0M	$53.0M	-$31.0M
Share-based compensation	$47.0M	$116.0M	$115.0M
Other, net	-$3.0M	$8.0M	$2.0M
Receivables	-$145.0M	-$78.0M	-$778.0M
Prepaid expenses and other current assets	$52.0M	-$57.0M	-$69.0M
Medical claims and benefits payable	-$132.0M	-$40.0M	$580.0M
Amounts due government agencies	-$591.0M	-$453.0M	$196.0M
Accounts payable, accrued liabilities and other	-$221.0M	$115.0M	$328.0M
Deferred revenue	-$51.0M	-$367.0M	$59.0M
Income taxes	-$201.0M	-$18.0M	-$2.0M
Net cash (used in) provided by operating activities	-$535.0M	$644.0M	$1.7B
Purchases of investments	-$751.0M	-$1.1B	-$1.4B
Proceeds from sales and maturities of investments	$1.4B	$1.1B	$772.0M
Net cash paid in business combinations	-$245.0M	-$344.0M	-$3.0M
Purchases of property, equipment and capitalized software	-$101.0M	-$100.0M	-$84.0M
Other, net	$1.0M	$1.0M	$4.0M
Net cash provided by (used in) investing activities	$312.0M	-$464.0M	-$744.0M
Proceeds from borrowings under credit facility and term loans	$1.1B	$300.0M	$0
Repayment of credit facility and term loans	-$1.1B	-$300.0M	$0
Common stock purchases	-$1.0B	-$1.0B	$0
Proceeds from senior notes offerings, net of issuance costs	$838.0M	$740.0M	$0
Common stock withheld to settle employee tax obligations	-$37.0M	-$57.0M	-$60.0M
Other, net	$29.0M	-$30.0M	$2.0M
Net cash used in financing activities	-$170.0M	-$347.0M	-$58.0M
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents	-$393.0M	-$167.0M	$860.0M
Cash paid during the period for interest	$181.0M	$121.0M	$108.0M

Compare Molina Healthcare with another company

Corporate structure

Molina Healthcare sits at the top of its group. 49 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Molina Healthcare

Lingotto Investment Management LLP Filed SCHEDULE 13G on Molina Healthcare, latest Sep 3, 2026
AQR CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G/A on Molina Healthcare, latest Aug 13, 2026 (4 filings since Nov 14, 2025)
Capital World Investors Filed SCHEDULE 13G/A on Molina Healthcare, latest Aug 12, 2026 (5 filings since Feb 11, 2022)
FMR LLC Filed SCHEDULE 13G/A on Molina Healthcare, latest Aug 6, 2026 (4 filings since Feb 9, 2023)
VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Molina Healthcare, latest Apr 30, 2026
VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Molina Healthcare, latest Apr 29, 2026
BlackRock Filed SCHEDULE 13G/A on Molina Healthcare, latest Apr 7, 2026 (5 filings since Feb 3, 2022)
VANGUARD GROUP INC Filed SCHEDULE 13G/A on Molina Healthcare, latest Mar 27, 2026 (5 filings since Feb 10, 2022)
PRICE T ROWE ASSOCIATES INC /MD/ Filed SCHEDULE 13G/A on Molina Healthcare, latest Feb 17, 2026 (9 filings since Feb 14, 2022)
Capital Research Global Investors Filed SCHEDULE 13G/A on Molina Healthcare, latest Aug 13, 2025 (2 filings since Nov 12, 2024)
Wellington Management Company Filed SC 13G/A on Molina Healthcare, latest Nov 8, 2024 (4 filings since Feb 4, 2022)
RENAISSANCE TECHNOLOGIES LLC Filed SC 13G/A on Molina Healthcare, latest Feb 10, 2022

Molina Healthcare Long Beach, California, United States
- 2028 West Broadway, LLC Subsidiary · Delaware, United States
- AlphaCare Holdings, Inc. Subsidiary · Delaware, United States
- Central Health Plan of California, Inc. Subsidiary · California, United States
- ConnectiCare Benefits, Inc. Subsidiary · Connecticut, United States
- ConnectiCare Capital, LLC Subsidiary · Connecticut, United States
- ConnectiCare Holding Company, Inc. Subsidiary · Connecticut, United States
- ConnectiCare Insurance Company, Inc. Subsidiary · Connecticut, United States
- ConnectiCare, Inc. Subsidiary · Connecticut, United States
- MHAZ, Inc. Subsidiary · Arizona, United States
- Molina Care Connections, LLC Subsidiary · Texas, United States
- Molina Clinical Services, LLC Subsidiary · Delaware, United States
- Molina Healthcare Data Center, LLC Subsidiary · New Mexico, United States
- Molina Healthcare of Arizona, Inc. Subsidiary · Arizona, United States
- Molina Healthcare of California Subsidiary · California, United States
- Molina Healthcare of Florida, Inc. Subsidiary · Florida, United States
- Molina Healthcare of Georgia, Inc. Subsidiary · Georgia, United States
- Molina Healthcare of Illinois, Inc. Subsidiary · Illinois, United States
- Molina Healthcare of Indiana, Inc. Subsidiary · Indiana, United States
- Molina Healthcare of Iowa, Inc. Subsidiary · Iowa, United States
- Molina Healthcare of Kansas, Inc. Subsidiary · Kansas, United States
- Molina Healthcare of Kentucky, Inc. Subsidiary · Kentucky, United States
- Molina Healthcare of Louisiana, Inc. Subsidiary · Louisiana, United States
- Molina Healthcare of Michigan, Inc. Subsidiary · Michigan, United States
- Molina Healthcare of Mississippi, Inc. Subsidiary · Mississippi, United States
- Molina Healthcare of Missouri, Inc. Subsidiary · Missouri, United States
- and 23 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Molina Healthcare reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$1.1B¹⁰ Dec 31, 2025	$1.0B¹⁰ Dec 31, 2024	+8.4%
Accumulated depreciation	$875.0M¹⁰ Dec 31, 2025	$806.0M¹⁰ Dec 31, 2024	+8.6%
Finance-lease assets	$61.0M¹⁰ Dec 31, 2025	$65.0M¹⁰ Dec 31, 2024	−6.2%
Operating-lease assets (leased space)	$30.0M¹⁰ Dec 31, 2025	$35.0M¹⁰ Dec 31, 2024	−14.3%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$4.2B¹⁰ Dec 31, 2025	$4.7B¹⁰ Dec 31, 2024	−8.9%
Marketable securities, current	$4.0B¹⁰ Dec 31, 2025	$4.3B¹⁰ Dec 31, 2024	−7.3%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$2.0B¹⁰ Dec 31, 2025	$1.7B¹⁰ Dec 31, 2024	+17.2%
Finite-lived intangibles, gross	$803.0M¹⁰ Dec 31, 2025	$742.0M¹⁰ Dec 31, 2024	+8.2%
Accumulated amortization	$566.0M¹⁰ Dec 31, 2025	$475.0M¹⁰ Dec 31, 2024	+19.2%
Finite-lived intangibles, net	$237.0M¹⁰ Dec 31, 2025	$267.0M¹⁰ Dec 31, 2024	−11.2%

Properties, in its own words

We own and lease certain real properties to support the business operations of our reportable segments. In 2022, we completed a plan to reduce the real estate footprint used in our business operations to accommodate our move to a permanent remote work environment, a model we have been working under successfully since 2020. Our remaining office space is being reconfigured and optimized for utilization and efficiency. While we believe our current and anticipated facilities are adequate to meet our operational needs in the near term, we continually evaluate the adequacy of our properties for our anticipated future needs.

Item 2 of the 10-K filed Feb 10, 2026.¹⁸

The story

Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Leadership

Who has led Molina Healthcare, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Joseph M. Zubretsky2017–now

Chief financial officer

Chief operating officer

1990200020102020

Chief executive officerJoseph M. Zubretsky Nov 6, 2017 to now¹⁹
Chief executive officerGeorge Kirk Olsen Jan 4, 2006 to Jan 3, 2007²⁰
Chief executive officerJoann Zarza-Garrido Jan 4, 2006 to Mar 7, 2006²¹
Chief executive officerRoman Kulich Feb 6, 2006 to Aug 23, 2007²²
PresidentJoseph M. Zubretsky Nov 6, 2017 to now¹⁹
Chief financial officerMark Lowell Keim Mar 3, 2021 to now²³
Chief financial officerJoseph W. Cpa White Mar 2, 2018 to Jun 6, 2018²⁴
Chief financial officerThomas L. Tran May 30, 2018 to Jul 2, 2020²⁵
Chief financial officerJohn C. Molina Sep 14, 2006 to Apr 4, 2017²⁶
Chief operating officerJames Woys Jul 3, 2023 to now²⁷
Chief operating officerTerry Bayer Jan 4, 2006 to Feb 6, 2018²⁸

Board members and other officers (40)

EVP, MedicaidDebra Bacon Feb 2, 2024 to now²⁹
Executive Vice PresidentMarc Russo Apr 1, 2020 to Aug 7, 2023³⁰
Chief Accounting OfficerMaurice Hebert Feb 19, 2019 to now³¹
Executive Vice PresidentMark Lowell Keim Mar 16, 2018 to Jan 11, 2021³²
Executive Vice PresidentPamela Sedmak Mar 16, 2018 to Mar 3, 2020³³
Executive Vice PresidentJames Woys May 22, 2018 to Mar 3, 2023³⁴
Senior Vice PresidentLisa A. Rubino Aug 11, 2016 to Mar 2, 2018³⁵
Chief Medical OfficerMichael M. Siegel Feb 16, 2007 to Mar 5, 2007³⁶
VP, Molina AdvantageGeorge Kirk Olsen Feb 28, 2007 to Jul 2, 2007³⁷
VP, ComplianceJoann Zarza-Garrido Mar 2, 2007 to Mar 2, 2007³⁸
Chief Medical OfficerJames W. Howatt May 29, 2007 to Mar 23, 2010³⁹
Chief Information OfficerAmir Desai Nov 15, 2007 to Aug 17, 2010⁴⁰
Regional Vice PresidentZarina Sparling Nov 15, 2007 to Jul 2, 2008⁴¹
VP, Internal AuditingHarvey A. Fein Jan 4, 2006 to Mar 5, 2007⁴²
VP, AccountingJoseph W. Cpa White Jan 4, 2006 to Apr 4, 2017⁴³
VP, Health Plan OperationsLillis Ann Koontz Jan 4, 2006 to Jul 2, 2008⁴⁴
Exec. VP, Shared ServicesSheila Shapiro Jan 4, 2006 to Jan 4, 2006⁴⁵
Chief Information OfficerRick Click Feb 6, 2006 to Mar 5, 2007⁴⁶
Chief Medical OfficerWilliam Bracciodieta Feb 6, 2006 to Feb 21, 2007⁴⁷
Exec. V.P., Financial AffairsJohn C. Molina Dec 13, 2006 to Dec 13, 2006⁴⁸
Board memberFrancis S. Soistman Jr. May 6, 2026 to now⁴⁹
Board memberLeo P. Grohowski May 2, 2025 to now⁵⁰
Board memberStephen H. Lockhart May 11, 2021 to now⁵¹
Board memberBarbara L. Brasier May 17, 2019 to now⁵²
Board memberRichard C. Zoretic Aug 1, 2018 to now⁵³
Board memberJoseph M. Zubretsky Nov 6, 2017 to now¹⁹
Board memberRichard M. Schapiro Aug 4, 2015 to now⁵⁴
Board memberDale B. Wolf Mar 13, 2013 to now⁵⁵
Board memberDaniel Cooperman Mar 13, 2013 to now⁵⁶
Board memberGarrey Carruthers Feb 22, 2012 to Apr 2, 2021⁵⁷
Board memberSteven J. Orlando Mar 2, 2006 to now⁵⁸
Board memberCharles Z. Fedak May 5, 2006 to Apr 3, 2019⁵⁹
Board memberFrank E. Murray Md. May 5, 2006 to Oct 2, 2017⁶⁰
Board memberJohn P. Szabo Jr. May 5, 2006 to Apr 3, 2015⁶¹
Board memberRonna Romney May 5, 2006 to now⁶²
Board memberSally K. Richardson May 5, 2006 to May 3, 2012⁶³
Board memberWayne B. Lowell Jun 14, 2006 to May 14, 2007⁶⁴
Board memberJohn C. Molina Sep 14, 2006 to Feb 28, 2018²⁶
General counselJeff D. Barlow Aug 10, 2012 to now⁶⁵
General counselMark L. Andrews Esq. Feb 6, 2006 to Jul 2, 2010⁶⁶

Products and brands

health insurance

Listed on Wikidata.¹

Entering the Medicare market

Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.

Entering MMIS market

Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.

Entering health insurance marketplace

In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

2028 West Broadway, LLC Delaware⁹
AlphaCare Holdings, Inc. Delaware⁹
Central Health Plan of California, Inc. California⁹
ConnectiCare Benefits, Inc. Connecticut⁹
ConnectiCare Capital, LLC Connecticut⁹
ConnectiCare Holding Company, Inc. Connecticut⁹
ConnectiCare Insurance Company, Inc. Connecticut⁹
ConnectiCare, Inc. Connecticut⁹
MHAZ, Inc. Arizona⁹
Molina Care Connections, LLC Texas⁹
Molina Clinical Services, LLC Delaware⁹
Molina Healthcare Data Center, LLC New Mexico⁹
Molina Healthcare of Arizona, Inc. Arizona⁹
Molina Healthcare of California California⁹
Molina Healthcare of Florida, Inc. Florida⁹
Molina Healthcare of Georgia, Inc. Georgia⁹
Molina Healthcare of Illinois, Inc. Illinois⁹
Molina Healthcare of Indiana, Inc. Indiana⁹
Molina Healthcare of Iowa, Inc. Iowa⁹
Molina Healthcare of Kansas, Inc. Kansas⁹
Molina Healthcare of Kentucky, Inc. Kentucky⁹
Molina Healthcare of Louisiana, Inc. Louisiana⁹
Molina Healthcare of Michigan, Inc. Michigan⁹
Molina Healthcare of Mississippi, Inc. Mississippi⁹

All 49 listed subsidiaries

Molina Healthcare of Missouri, Inc. Missouri⁹
Molina Healthcare of Nebraska, Inc. Nebraska⁹
Molina Healthcare of Nevada, Inc. Nevada⁹
Molina Healthcare of New Mexico, Inc. New Mexico⁹
Molina Healthcare of New York, Inc. New York⁹
Molina Healthcare of North Carolina, Inc. North Carolina⁹
Molina Healthcare of Ohio, Inc. Ohio⁹
Molina Healthcare of Oklahoma, Inc. Oklahoma⁹
Molina Healthcare of Pennsylvania, Inc. Pennsylvania⁹
Molina Healthcare of Rhode Island Holding Company, Inc. Delaware⁹
Molina Healthcare of Rhode Island, Inc. Rhode Island⁹
Molina Healthcare of South Carolina, Inc. South Carolina⁹
Molina Healthcare of Tennessee, Inc. Tennessee⁹
Molina Healthcare of Texas Insurance Company Texas⁹
Molina Healthcare of Texas, Inc. Texas⁹
Molina Healthcare of Utah, Inc. Utah⁹
Molina Healthcare of Virginia, LLC Virginia⁹
Molina Healthcare of Washington, Inc. Washington⁹
Molina Healthcare of Wisconsin, Inc. Wisconsin⁹
SWH Holdings, Inc. Delaware⁹
Senior Health Holdings, Inc. Delaware⁹
Senior Health Holdings, LLC Delaware⁹
Senior Whole Health of New York, Inc. New York⁹
Senior Whole Health, LLC Massachusetts⁹
The Management Group, LLC Wisconsin⁹

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

MOLINA HEALTHCARE INCDec 30, 2002 to Jul 3, 2019⁷

Controversies and legal

Criticism and controversies

A 2023 report investigating "High Rates of Prior

Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Timeline

Jul 22, 20268-K Results of operations⁶⁷
Jun 10, 20268-K Regulation FD disclosure⁶⁸
May 11, 20268-K Executive or director change; Bylaws or fiscal year changed; Shareholder vote⁶⁹
May 8, 20268-K Regulation FD disclosure⁷⁰
Apr 22, 20268-K Results of operations⁷¹
Feb 26, 20268-K Regulation FD disclosure⁷²
Feb 6, 20268-K Entered a material agreement; New debt or obligation; Impairment⁷³
Feb 5, 20268-K Results of operations⁷⁴
Nov 20, 20258-K Entered a material agreement; New debt or obligation; Other events⁷⁵
Nov 18, 20258-K Regulation FD disclosure⁷⁶
Nov 17, 20258-K Regulation FD disclosure⁷⁷
Nov 14, 20258-K Regulation FD disclosure⁷⁸
Nov 6, 2017New chief executive Joseph M. Zubretsky becomes CEO¹⁹
Feb 6, 2006New chief executive Roman Kulich becomes CEO²²
Jan 4, 2006New chief executive Joann Zarza-Garrido becomes CEO²¹
Jan 4, 2006New chief executive George Kirk Olsen becomes CEO²⁰
1980Founded Founded¹

Calendar

Coming up

Oct 21, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.84 a share, on Oct 22, 2025.⁷⁹

When it reported results

Jul 22, 2026Reported quarterly or annual results⁶⁷
Apr 22, 2026Reported quarterly or annual results⁷¹
Feb 5, 2026Reported quarterly or annual results⁷⁴
Oct 22, 2025Reported quarterly or annual results⁸⁰
Jul 23, 2025Reported quarterly or annual results⁸¹
Jul 7, 2025Reported quarterly or annual results⁸²
Apr 23, 2025Reported quarterly or annual results⁸³
Feb 5, 2025Reported quarterly or annual results⁸⁴

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

477 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 77 major events, 290 insider forms, 42 large holders, 48 other. The latest 20:

Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Sep 3, 2026SCHEDULE 13G EDGAR
Aug 13, 2026SCHEDULE 13G/A EDGAR
Aug 12, 2026SCHEDULE 13G/A EDGAR
Aug 6, 2026SCHEDULE 13G/A EDGAR
Jul 23, 202610-Q EDGAR
Jul 22, 20268-K EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR

The 477 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

68 open-market trades by officers, directors and large owners since October 2021: 2 buys and 66 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
May 14, 2026	HEBERT MAURICEChief Accounting Officer	Sale	600	$191.55	$114.9K	Form 4
May 11, 2026	Barlow Jeff D.Chief Legal Officer	Sale	17,811	$186.12	$3.3M	Form 4
Mar 12, 2026	ROMNEY RONNADirector	Sale	506	$146.92	$74.3K	Form 4
Feb 11, 2026	ZORETIC RICHARD CDirector	Buy	800	$125.16	$100.1K	Form 4
Nov 24, 2025	Schapiro Richard MDirector	Sale	357	$143.02	$51.1K	Form 4
Aug 6, 2025	ROMNEY RONNADirector	Sale	700	$153.74	$107.6K	Form 4
Aug 4, 2025	WOYS JAMESChief Operating Officer	Buy	10,000	$155.94	$1.6M	Form 4
May 21, 2025	WOLF DALE BDirector	Sale	1,500	$322.89	$484.3K	Form 4
May 5, 2025	ORLANDO STEVEN JDirector	Sale	1,000	$318.58	$318.6K	Form 4
Apr 30, 2025	Zubretsky Joseph MPresident & CEO	Sale	87,500	$320.06	$28.0M	Form 4
Apr 29, 2025	Schapiro Richard MDirector	Sale	669	$320.50	$214.4K	Form 4
Mar 3, 2025	ORLANDO STEVEN JDirector	Sale	1,000	$301.33	$301.3K	Form 4
Nov 18, 2024	Schapiro Richard MDirector	Sale	136	$292.72	$39.8K	Form 4
Aug 15, 2024	HEBERT MAURICEChief Accounting Officer	Sale	393	$346.52	$136.2K	Form 4
Jul 30, 2024	ORLANDO STEVEN JDirector	Sale	1,000	$339.21	$339.2K	Form 4
Jul 29, 2024	Barlow Jeff D.Chief Legal Officer	Sale	5,340	$335.00	$1.8M	Form 4
May 22, 2024	WOYS JAMESChief Operating Officer	Sale	10,000	$345.15	$3.5M	Form 4
May 21, 2024	ROMNEY RONNADirector	Sale	250	$343.27	$85.8K	Form 4
Feb 20, 2024	Schapiro Richard MDirector	Sale	1,000	$401.05	$401.1K	Form 4
Feb 15, 2024	ORLANDO STEVEN JDirector	Sale	750	$399.12	$299.3K	Form 4

All 68 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Lingotto Investment Management LLPSCHEDULE 13G, 1 filing Sep 3, 2026⁸⁵
AQR CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 4 filings Nov 14, 2025 to Aug 13, 2026⁸⁶
Capital World InvestorsSCHEDULE 13G/A, 5 filings Feb 11, 2022 to Aug 12, 2026⁸⁷
FMR LLCSCHEDULE 13G/A, 4 filings Feb 9, 2023 to Aug 6, 2026⁸⁸
VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 2026⁸⁹
VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 2026⁹⁰
BlackRockSCHEDULE 13G/A, 5 filings Feb 3, 2022 to Apr 7, 2026⁹¹
VANGUARD GROUP INCSCHEDULE 13G/A, 5 filings Feb 10, 2022 to Mar 27, 2026⁹²
PRICE T ROWE ASSOCIATES INC /MD/SCHEDULE 13G/A, 9 filings Feb 14, 2022 to Feb 17, 2026⁹³
Capital Research Global InvestorsSCHEDULE 13G/A, 2 filings Nov 12, 2024 to Aug 13, 2025⁹⁴
Wellington Management CompanySC 13G/A, 4 filings Feb 4, 2022 to Nov 8, 2024⁹⁵
RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 1 filing Feb 10, 2022⁹⁶

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Year	Executive	Salary	Total pay
2025	Joseph M. ZubretskyPresident and Chief Executive Officer	$1.6M	$18.3M⁹⁷
2025	Mark L. KeimChief Financial Officer	$1.0M	$7.6M⁹⁷
2025	James E. WoysChief Operating Officer	$800.0K	$5.4M⁹⁷
2025	Jeff D. BarlowChief Legal Officer and Secretary	$685.0K	$4.4M⁹⁷
2025	Debra J. BaconExecutive Vice President, Medicaid	$675.0K	$2.9M⁹⁷
2024	Joseph M. ZubretskyPresident and Chief Executive Officer	$1.6M	$21.9M⁹⁷
2024	Mark L. KeimChief Financial Officer	$850.0K	$7.0M⁹⁷
2024	James E. WoysChief Operating Officer	$800.0K	$6.2M⁹⁷
2024	Jeff D. BarlowChief Legal Officer and Secretary	$685.0K	$4.8M⁹⁷
2024	Debra J. BaconExecutive Vice President, Medicaid	$675.0K	$3.6M⁹⁷
2023	Joseph M. ZubretskyPresident and Chief Executive Officer	$1.5M	$21.5M⁹⁷
2023	Mark L. KeimChief Financial Officer	$850.0K	$6.4M⁹⁷
2023	James E. WoysChief Operating Officer	$800.0K	$5.5M⁹⁷
2023	Jeff D. BarlowChief Legal Officer and Secretary	$685.0K	$4.9M⁹⁷

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
BlackRock, Inc.	6,572,156	$1.5B	0.0%	+203,130
Aqr Capital Management LLC	3,560,601	$806.9M	0.3%	+697,208
Vanguard Portfolio Management LLC	2,790,243	$638.1M	0.0%	−728
Capital World Investors	2,562,913	$586.1M	0.1%	−636,433
Lingotto Investment Management LLP	2,511,490	$574.4M	12.4%	New
Vanguard Capital Management LLC	2,355,261	$538.6M	0.0%	+45,031
Victory Capital Management Inc	1,980,615	$453.0M	0.3%	−90,084
Fmr LLC	1,871,290	$428.0M	0.0%	−1,333,634
State Street Corp	1,755,467	$401.5M	0.0%	+25,026
Dimensional Fund Advisors LP	1,393,338	$318.7M	0.1%	−1,544
Goldman Sachs Group Inc	1,306,563	$298.8M	0.0%	+579,678
Wellington Management Group Llp	1,267,207	$289.8M	0.1%	+135,247
Two Sigma Investments, LP	1,266,338	$289.6M	0.2%	−84,357
Capital Research Global Investors	1,092,251	$249.8M	0.0%	+4,446
Morgan Stanley	1,007,068	$230.3M	0.0%	+1,071
Harris Associates L P	957,500	$219.0M	0.3%	−20,647
Geode Capital Management, LLC	891,772	$204.0M	0.0%	−29,241
Manning & Napier Advisors LLC	663,669	$152.3M	2.0%	+118,252
UBS Group AG	624,180	$142.7M	0.0%	+151,704
Long Focus Capital Management, LLC	610,000	$139.5M	5.7%	−5,000
Charles Schwab Investment Management Inc	575,045	$131.5M	0.0%	+35,733
Invesco Ltd.	508,669	$116.3M	0.0%	+1,029
Jacobs Levy Equity Management, Inc	505,241	$115.5M	0.4%	+154,296
Northern Trust Corp	386,064	$88.3M	0.0%	+3,011
Norges Bank	380,649	$87.1M	0.0%	New

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

11 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Nov 12, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	−37.7%	Report
Sep 4, 2025	Byron DonaldsRepublican, House	Sale	$1,001 - $15,000	−5.5%	Report
Sep 4, 2025	Byron DonaldsRepublican, House	Sale	$1,001 - $15,000	−5.5%	Report
Aug 5, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	+14.0%	Report
May 30, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	+61.3%	Report
May 15, 2025	Robert P. Bresnahan, Jr.Republican, House	Buy	$1,001 - $15,000	−63.0%	Report
Apr 29, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−72.8%	Report
Jan 13, 2025	Robert P. Bresnahan, Jr.Republican, House	Sale	$1,001 - $15,000	+60.6%	Report
Jul 12, 2023	Daniel S. GoldmanDemocratic, House	Sale	$15,001 - $50,000	+100.2%	Report
Jun 15, 2023	Earl Blumenauer, House	Buy	$15,001 - $50,000	−99.5%	Report
Apr 10, 2023	Daniel S. GoldmanDemocratic, House	Buy	$15,001 - $50,000	−115.1%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Molina Healthcare is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARMOLINA HEALTHCARE, INC.²
CIK0001179929
Employer ID (EIN)13-4204626¹⁸
Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company¹⁸
Incorporated inDelaware¹⁸
Fiscal year endsDecember 31²
Industry code (SIC)6324 Hospital & Medical Service Plans²
SEC reviewing officeOffice of Finance, Division of Corporation Finance²
Business address200 Oceangate, Suite 100, Long Beach, CA 90802²
Phone5624353666²
Shares outstanding52,200,000 as of Jul 17, 2026¹⁷
Public float$16.0B as of Jun 30, 2025¹⁸
AuditorErnst & Young LLP, Los Angeles, California PCAOB ID 42; it also attests to the company’s internal control over financial reporting¹⁸
On EDGAR sinceDec 30, 2002²
Filings2,681 in all: 4 (1,708), 8-K (424), SC 13G (81), SC 13G/A (74), 10-Q (70), 3 (38), 4/A (34), 144 (31)²
All 43 form types
CORRESP (26), DEF 14A (24), 10-K (23), UPLOAD (22), 8-K/A (14), ARS (14), DEFA14A (13), SCHEDULE 13G/A (12), S-1/A (8), S-8 (8), SCHEDULE 13G (8), 424B5 (7), CT ORDER (5), PRE 14A (5), 5 (3), 10-Q/A (2), 424B3 (2), EFFECT (2), S-1 (2), S-3 (2), S-3/A (2), S-3ASR (2), S-4 (2), SC 13D/A (2), 10-K/A (1), 305B2 (1), 424B1 (1), 424B4 (1), 8-A12B (1), D (1), FWP (1), POS AM (1), S-1MEF (1), S-8 POS (1), SC 13D (1)
Latest filingsAnnual report (10-K) Feb 10, 2026
Quarterly report (10-Q) Jul 23, 2026
Proxy statement (DEF 14A) Mar 23, 2026
Latest 8-K (8-K) Jul 22, 2026

Securities registered for trading

Class	Symbol	Exchange
Common Stock, $0.001 Par Value	MOH	New York Stock Exchange

From the cover page of the 10-K filed Feb 10, 2026 (Section 12(b) of the Exchange Act).¹⁸

Risk factors and legal proceedings

The risks Molina Healthcare names in Item 1A of its 10-K filed Feb 10, 2026: 40 risks under these headings, as written.¹⁸

RISKS RELATED TO OUR BUSINESS
The Medicaid rates paid to us by states may be insufficient to cover our rising medical care costs.
Our Marketplace business has been volatile and unpredictable, and has been subject to annual programmatic changes that are difficult to price for actuarially.
Our health plans operate with very low profit margins, and small changes in operating performance or slight changes to our accounting estimates could have a disproportionate impact on our reported net income.
If we fail to accurately predict and effectively manage our medical care costs, our operating results could be materially and adversely affected.
Our Medicaid premium revenues could be adversely impacted by retroactive adjustments or recoupments, or states’ delays in implementing rate changes.
If the responsive bids of our health plans for new or renewed Medicaid contracts are not successful, or if our government contracts are terminated or are not renewed on favorable terms, our premium revenues could be materially reduced, our operating results could be negatively impacted, and we may not realize the full projected amount of our embedded earnings.
We are subject to risks associated with outsourcing services and functions to third parties.
We and our third-party service providers are exposed to cybersecurity risks, which may result in operational impact, increased costs, exposure to significant legal liability, reputational harm, loss of business, and other serious negative consequences.
We may be unable to successfully integrate our acquisitions or realize the anticipated benefits of such acquisitions, including the full realization of our embedded earnings.
We may be unable to sustain our projected rate of growth due to a lack of merger and acquisition opportunities.
Failure to attain profitability in any newly acquired health plans or new start-up operations could negatively affect our results of operations.

The other 29 risks

If we lose contracts that constitute a significant amount of our premium revenue, we will lose the administrative cost efficiencies or cost leverage that is inherent in a larger revenue base.
Our health plans are subject to risk associated with various contractual provisions and regulations establishing medical cost expenditure floors, profit ceilings, risk corridors, or quality withholds.
If, in the interest of long-term profitability, we decide to exit certain state contractual arrangements, make changes to our provider networks, or make changes to our administrative infrastructure, we may suffer disruptions to our business that could in the short term materially reduce our premium revenues and our net income.
A failure to accurately estimate incurred but not paid medical care costs may negatively impact our results of operations.
If we are unable to deliver quality care, and maintain good relations with the physicians, hospitals, and other providers with whom we contract, or if we are unable to enter into cost-effective contracts with such providers, our profitability could be adversely affected.
We rely on the accuracy of eligibility lists provided by state governments. Inaccuracies in those lists could negatively affect our results of operations.
The insolvency of a delegated provider could obligate us to pay its referral claims, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations.
If a state fails to renew its federal waiver application for mandated Medicaid enrollment into managed care or such application is denied, our membership in that state will likely decrease.
Our business depends on our information and medical management systems, and our inability to effectively integrate, manage, update, and keep secure our information and medical management systems could disrupt our operations.
Our encounter data, or the encounter data of the health plans we acquire, may be inaccurate or incomplete, which could have a material adverse effect on our business, financial condition, cash flows, or results of operations, and on our ability to bid for, and continue to participate in, certain programs.
We may not be successful in our AI administrative and operational initiatives, which could adversely affect our business or reputation.
An impairment charge with respect to our recorded goodwill, or our finite-lived intangible assets, could have a material impact on our financial results.
The value of our investments is influenced by varying economic and market conditions, and a decrease in value may result in a loss charged to income.
RISKS RELATED TO OUR INDUSTRY
Medicaid enrollees continue to be subject to eligibility redeterminations and potential disenrollments on a state by state basis, and the number and health acuity level of Medicaid enrollees we retain may be lower than our current estimates.
CMS has now ended the MMP program, which programmatic change could impact our premium revenues.
If state regulators do not approve payments of dividends and distributions by our subsidiaries, it may negatively affect our ability to meet our debt service and other obligations.
We are subject to extensive fraud and abuse laws that may give rise to lawsuits and claims against us, the outcome of which may have a material adverse effect on our business, financial condition, cash flows, or results of operations.
Unforeseen changes in pharmaceutical regulations or market conditions may impact our revenues and adversely affect our results of operations.
Increases in our pharmaceutical costs could have a material adverse effect on the level of our medical costs and our results of operations.
Large-scale medical emergencies in one or more states in which we operate our health plans could significantly increase utilization rates and medical costs.
We face various risks inherent in the government contracting process that could materially and adversely affect our business and profitability, including periodic routine and non-routine reviews, audits, and investigations by government agencies.
Any changes to the laws and regulations governing our business, or the interpretation and enforcement of those laws or regulations implemented by the Trump administration, could require us to modify our operations and could negatively impact our operating results.
Adverse credit market conditions may have a material adverse effect on our liquidity or our ability to obtain credit on acceptable terms.
Restrictive covenants in our debt instruments may restrict our ability to pursue our business strategies or have other adverse consequences.
GENERAL RISK FACTORS
We are dependent on the leadership of our chief executive officer and other executive officers and key employees.
We face risks related to litigation or arbitration.
Failure to maintain effective internal controls over financial reporting could have a material adverse effect on our business, operating results, and stock price, and could subject us to sanctions by regulatory authorities.
Because our corporate headquarters are located in Southern California, our business operations may be disrupted as a result of a major earthquake or wildfire.
Changes in tax laws or regulations that are applied adversely to us or our customers may materially adversely affect our business, prospects, financial condition and operating results.

Legal proceedings

For information regarding legal proceedings, see the Notes to Consolidated Financial Statements, Note 15, “Commitments and Contingencies—Legal Proceedings.”

The opening of Item 3, Legal Proceedings.¹⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataMolina Healthcare on Wikidata
2
SEC EDGARMolina Healthcare filings on SEC EDGAR
3
WikipediaMolina Healthcare on Wikipedia
4
GLEIFMolina Healthcare LEI record (549300NQQCEQ46YHZ591)
5
Yahoo FinanceMOH quote
6
Wikimedia CommonsMolina Healthcare logo by Molina Healthcare, Public domain
7
SEC EDGARMolina Healthcare filings on SEC EDGAR
8
WikipediaMolina Healthcare on Wikipedia (revision used)
9
SEC EDGARMolina Healthcare annual report, Exhibit 21 (subsidiaries)
10
SEC EDGARMolina Healthcare 10-K for fiscal 2025
11
SEC EDGARMolina Healthcare 10-K for fiscal 2019
12
SEC EDGARMolina Healthcare 10-K for fiscal 2020
13
SEC EDGARMolina Healthcare 10-K for fiscal 2021
14
SEC EDGARMolina Healthcare 10-K for fiscal 2022
15
SEC EDGARMolina Healthcare 10-K for fiscal 2019
16
SEC EDGARMolina Healthcare 10-Q for fiscal 2026
17
SEC EDGARMolina Healthcare 10-Q for fiscal 2026
18
SEC EDGARMolina Healthcare 10-K filed Feb 10, 2026: Item 2, Properties
19
SEC EDGARJoseph M. Zubretsky, Chief executive officer
20
SEC EDGARGeorge Kirk Olsen, Chief executive officer
21
SEC EDGARJoann Zarza-Garrido, Chief executive officer
22
SEC EDGARRoman Kulich, Chief executive officer
23
SEC EDGARMark Lowell Keim, Chief financial officer
24
SEC EDGARJoseph W. Cpa White, Chief financial officer
25
SEC EDGARThomas L. Tran, Chief financial officer
26
SEC EDGARJohn C. Molina, Chief financial officer
27
SEC EDGARJames Woys, Chief operating officer
28
SEC EDGARTerry Bayer, Chief operating officer
29
SEC EDGARDebra Bacon, EVP, Medicaid
30
SEC EDGARMarc Russo, Executive Vice President
31
SEC EDGARMaurice Hebert, Chief Accounting Officer
32
SEC EDGARMark Lowell Keim, Executive Vice President
33
SEC EDGARPamela Sedmak, Executive Vice President
34
SEC EDGARJames Woys, Executive Vice President
35
SEC EDGARLisa A. Rubino, Senior Vice President
36
SEC EDGARMichael M. Siegel, Chief Medical Officer
37
SEC EDGARGeorge Kirk Olsen, VP, Molina Advantage
38
SEC EDGARJoann Zarza-Garrido, VP, Compliance
39
SEC EDGARJames W. Howatt, Chief Medical Officer
40
SEC EDGARAmir Desai, Chief Information Officer
41
SEC EDGARZarina Sparling, Regional Vice President
42
SEC EDGARHarvey A. Fein, VP, Internal Auditing
43
SEC EDGARJoseph W. Cpa White, VP, Accounting
44
SEC EDGARLillis Ann Koontz, VP, Health Plan Operations
45
SEC EDGARSheila Shapiro, Exec. VP, Shared Services
46
SEC EDGARRick Click, Chief Information Officer
47
SEC EDGARWilliam Bracciodieta, Chief Medical Officer
48
SEC EDGARJohn C. Molina, Exec. V.P., Financial Affairs
49
SEC EDGARFrancis S. Soistman Jr., Board member
50
SEC EDGARLeo P. Grohowski, Board member
51
SEC EDGARStephen H. Lockhart, Board member
52
SEC EDGARBarbara L. Brasier, Board member
53
SEC EDGARRichard C. Zoretic, Board member
54
SEC EDGARRichard M. Schapiro, Board member
55
SEC EDGARDale B. Wolf, Board member
56
SEC EDGARDaniel Cooperman, Board member
57
SEC EDGARGarrey Carruthers, Board member
58
SEC EDGARSteven J. Orlando, Board member
59
SEC EDGARCharles Z. Fedak, Board member
60
SEC EDGARFrank E. Murray Md., Board member
61
SEC EDGARJohn P. Szabo Jr., Board member
62
SEC EDGARRonna Romney, Board member
63
SEC EDGARSally K. Richardson, Board member
64
SEC EDGARWayne B. Lowell, Board member
65
SEC EDGARJeff D. Barlow, General counsel
66
SEC EDGARMark L. Andrews Esq., General counsel
67
SEC EDGARResults of operations
68
SEC EDGARRegulation FD disclosure
69
SEC EDGARExecutive or director change; Bylaws or fiscal year changed; Shareholder vote
70
SEC EDGARRegulation FD disclosure
71
SEC EDGARResults of operations
72
SEC EDGARRegulation FD disclosure
73
SEC EDGAREntered a material agreement; New debt or obligation; Impairment
74
SEC EDGARResults of operations
75
SEC EDGAREntered a material agreement; New debt or obligation; Other events
76
SEC EDGARRegulation FD disclosure
77
SEC EDGARRegulation FD disclosure
78
SEC EDGARRegulation FD disclosure
79
NasdaqNasdaq calendar
80
SEC EDGARMolina Healthcare 8-K, Item 2.02 (results of operations)
81
SEC EDGARMolina Healthcare 8-K, Item 2.02 (results of operations)
82
SEC EDGARMolina Healthcare 8-K, Item 2.02 (results of operations)
83
SEC EDGARMolina Healthcare 8-K, Item 2.02 (results of operations)
84
SEC EDGARMolina Healthcare 8-K, Item 2.02 (results of operations)
85
SEC EDGARLingotto Investment Management LLP SCHEDULE 13G on Molina Healthcare
86
SEC EDGARAQR CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Molina Healthcare
87
SEC EDGARCapital World Investors SCHEDULE 13G/A on Molina Healthcare
88
SEC EDGARFMR LLC SCHEDULE 13G/A on Molina Healthcare
89
SEC EDGARVANGUARD CAPITAL MANAGEMENT LLC SCHEDULE 13G on Molina Healthcare
90
SEC EDGARVANGUARD PORTFOLIO MANAGEMENT LLC SCHEDULE 13G on Molina Healthcare
91
SEC EDGARBlackRock SCHEDULE 13G/A on Molina Healthcare
92
SEC EDGARVANGUARD GROUP INC SCHEDULE 13G/A on Molina Healthcare
93
SEC EDGARPRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G/A on Molina Healthcare
94
SEC EDGARCapital Research Global Investors SCHEDULE 13G/A on Molina Healthcare
95
SEC EDGARWellington Management Company SC 13G/A on Molina Healthcare
96
SEC EDGARRENAISSANCE TECHNOLOGIES LLC SC 13G/A on Molina Healthcare
97
SEC EDGARMolina Healthcare proxy statement (DEF 14A), 2025 pay

Overview

Financials

Key numbers, fiscal 2025

Where the money goes

Where each dollar of revenue went, fiscal 2025

Financial statements

Corporate structure

What it owns

Property and equipment

Investments

Intangibles and goodwill

Properties, in its own words

The story

Leadership

Chief executive

President

Chief financial officer

Chief operating officer

Products and brands

Entering the Medicare market

Entering MMIS market

Entering health insurance marketplace

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

Former names

Controversies and legal

Criticism and controversies

Timeline

Calendar

Coming up

When it reported results

Filings

Insider trades

Major holders

Executive pay

Held by these funds

Members of Congress who traded it

SEC filer profile

Securities registered for trading

Risk factors and legal proceedings

Legal proceedings

Links

Sources